Long-term efficacy of dose intensified interferon-α 2b and ribavirin therapy for hepatitis C in HIV-coinfected patients

被引：0
|
作者：
Mannah, M [1 ]
Rockstroh, JK [1 ]
Gölz, J [1 ]
Klausen, G [1 ]
Dupke, S [1 ]
Stein, L [1 ]
Notheis, G [1 ]
Stoehr, A [1 ]
Mauss, S [1 ]
机构：
[1] Univ Bonn, Neurol Klin, D-53105 Bonn, Germany
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W901
引用
收藏
页码：A528 / A528
页数：1
相关论文
共 50 条
  • [31] Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment
    Malaguarnera, M
    Pistone, G
    Neri, S
    Romano, M
    Brogna, A
    Musumeci, S
    BIODRUGS, 2004, 18 (06) : 407 - 413
  • [32] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [33] Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C
    Dieperink, E
    Ho, SB
    Tetrick, L
    Thuras, P
    Dua, K
    Willenbring, ML
    GENERAL HOSPITAL PSYCHIATRY, 2004, 26 (03) : 237 - 240
  • [34] Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C)
    Sherman, Kenneth E.
    Andersen, Janet W.
    Butt, Adeel A.
    Umbleja, Triin
    Alston, Beverly
    Koziel, Margaret J.
    Peters, Marion G.
    Sulkowski, Mark
    Goodman, Zachary D.
    Chung, Raymond T.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (05) : 597 - 605
  • [35] Current management and recommendations on hepatitis B therapy in HIV-coinfected patients
    Piroth, Lionel
    Mahy, Sophie
    Pol, Stanislas
    Carrat, Fabrice
    Sene, Damien
    Etienne, Manuel
    Lascoux-Combe, Caroline
    Simon, Anne
    Schmit, Jean-Luc
    Cacoub, Patrice
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 437 - 442
  • [36] British HIV guidelines for the management of hepatitis B and C in HIV-coinfected patients
    Nuñez, M
    AIDS REVIEWS, 2005, 7 (03) : 181 - 181
  • [37] Pegylated interferon-α2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study
    Lang, Jean-Philippe
    Melin, Pascal
    Ouzan, Denis
    Rotily, Michel
    Fontanges, Thierry
    Marcellin, Patrick
    Chousterman, Michel
    Cacoub, Patrice
    ANTIVIRAL THERAPY, 2010, 15 (04) : 599 - 606
  • [38] Diabetes mellitus reduces the therapeutic effectiveness of interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Konishi, Ichiro
    Horiike, Norio
    Hiasa, Yoichi
    Tokumoto, Yoshio
    Mashiba, Toshie
    Michitaka, Kojiro
    Miyake, Yasuyuki
    Nonaka, Suguru
    Joukou, Kouji
    Matsuura, Bunzo
    Onji, Morikazu
    HEPATOLOGY RESEARCH, 2007, 37 (05) : 331 - 336
  • [39] Hepatitis C virus genotype 4 and response to combination therapy with interferon-α2b plus ribavirin
    Bruno, S
    Crosignani, A
    Pinzello, GB
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (11) : 922 - 923
  • [40] High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-α monotherapy
    Hass, Holger G.
    Kreysel, Christian
    Fischinger, Johannes
    Menzel, Josef
    Kaiser, Stephan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (34) : 5342 - 5346
12345